AstraZeneca Forms New Company for Bispecific Antibodies
By

By
AstraZeneca, through MedImmune, its global biologics research and development arm, has formed a collaboration with Abpro, a Woburn, Massachusetts-based life-sciences company, to advance the development of a preclinical, bispecific antibody…

Mylan Recalls Over 100,000 Units of Generic Anti-Seizure Drug
By

By
Mylan has issued a voluntarily Class III recall for more than 100,000 units of clonazepam, its generic version of Roche’s Klonopin (clonazepam), due to an out-of-specification result for clonazepam-related compound…

Patheon in Manufacturing Deal
By

By
Patheon Manufacturing Services was approved by the US Food and Drug Administration (FDA) as the second contract manufacturer of Auryxia (ferric citrate), a drug used during dialysis, for Keryx Biopharmaceuticals,…

iBio Expands Plant-Based Protein Production
By

By
iBio, a New York-based plant-based biotechnology company, has completed the product development capacity expansion of its subsidiary, iBio CMO, for production of pharmaceutical proteins in hydroponically-grown green plants. iBio is…

Imprimis in Supply Pact
By

By
Imprimis Pharmaceuticals, a San Diego-based pharmaceutical company, has entered into a product purchase and supply agreement with the specialty pharmacy division of an unnamed major pharmacy benefit manager (PBM) company…

Saneca, Menarini in Supply Pact
By

By
Saneca Pharma, a Hlohovec, Slovakia-based contract development and manufacturing organization (CDMO), has secured an agreement with Menarini Group, a Florence, Italy-based pharmaceutical company, to deliver controlled-release pellets for one of…

JHL Biotech in mAb Manufacturing Pact
By

By
JHL Biotech, a Hsinchu, Taiwan-based contract manufacturing organization, has formed a manufacturing services partnership with Aslan Pharmaceuticals, a Singapore-based biotechnology company focused on immunotherapies and targeted agents for Asia-prevalent tumor…

Allergan, BMS, Gilead, and Pfizer Lead Drug Approvals
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Allergan, BMS, Gilead, and Pfizer. Editor’s Note: This article is updated on a continuous basis for…

AbbVie, Gilead, Novartis, and Sanofi Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from AbbVie, Gilead, Novartis, Novo Nordisk, and Sanofi. Editor’s Note:…

BMS in siRNA Therapy License Agreement
By

By
Bristol-Myers Squibb (BMS) has entered into an agreement with Nitto Denko Corporation, an Osaka, Japan-based materials manufacturer, which grants BMS exclusive worldwide rights for the development and commercialization of Nitto’s…